ACTRN12608000535370已完成4 期
Phase IV study, randomized, placebo-controlled for the evaluation of efficacy and tolerability of arginine aspartate in patients with moderate to severe fatigue
ikkho Zydus0 个研究点目标入组 60 人开始时间: 2008年10月22日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Patients between 18 to 70 years old
- •Informed consent
- •Rate = or more than 4 in the Piper Scale
排除标准
- •Organic disease
研究者
相似试验
进行中（未招募）
不适用
The cardiovascular, renal and gastrointestinal effects of the gut-hormone based therapies liraglutide and sitagliptiMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 2 Diabetes MellitusEUCTR2012-003256-36-NLVU University Medical Center
已完成
4 期
A phase IV, randomized, double-blind, placebo-controlled, parallel-group trial to assess the effect of 12-week treatment with the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide or dipeptidyl peptidase-4 inhibitor (DPP-4i) sitagliptin on the cardiovascular, renal and gastrointestinal system in insulin-naïve patients with type 2 diabetes (T2DM).10018424Type 2 Diabetes MellitusNL-OMON41271Vrije Universiteit Medisch Centrum70
进行中（未招募）
不适用
Study to evaluate immunogenicity, reactogenicity and safety of Rotarix™ vaccine in Korean infants.Rotavirus gateroenteritisEUCTR2015-001545-81-Outside-EU/EEAGlaxoSmithKline Biologicals684
招募中
4 期
A phase IV, blinded, randomized controlled trial to compare the effectiveness of low pressure pneumoperitoneum during laparoscopic donor nephrectomy to optimize the quality-of-recovery during the early post-operative phasedonor nephrectomykidney donation1003843010038365NL-OMON40838niversitair Medisch Centrum Sint Radboud64
进行中（未招募）
不适用
Clinical trial to evaluate the immune response and safety of a combined Tdap vaccine(Boostrix, GSK) and antipapilloma human virus vaccine (Gardasil) vaccine when administered with the meningococcal conjugate ACWY Novartis or placebo.Menveo is indicated for active immunization of adolescents (from 11 years of age) and adults at risk of exposure to Neisseria meningitidis groups A, C, W135 and Y, to prevent invasive disease.MedDRA version: 14.1Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10027276Term: Meningococcal meningitisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-000476-34-ITOVARTIS VACCINES AND DIAGNOSTICS S.R.L.800